ZA200705145B - Rescue of influenza virus - Google Patents

Rescue of influenza virus

Info

Publication number
ZA200705145B
ZA200705145B ZA200705145A ZA200705145A ZA200705145B ZA 200705145 B ZA200705145 B ZA 200705145B ZA 200705145 A ZA200705145 A ZA 200705145A ZA 200705145 A ZA200705145 A ZA 200705145A ZA 200705145 B ZA200705145 B ZA 200705145B
Authority
ZA
South Africa
Prior art keywords
rescue
influenza virus
influenza
virus
Prior art date
Application number
ZA200705145A
Other languages
English (en)
Inventor
De Wit Emmie
Ron A M Foucher
Monique I J Spronken
Albert D M E Osterhaus
Original Assignee
Solvay Pharm Bv
Univ Erasmus Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv, Univ Erasmus Medical Ct filed Critical Solvay Pharm Bv
Publication of ZA200705145B publication Critical patent/ZA200705145B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18651—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA200705145A 2004-12-24 2007-06-21 Rescue of influenza virus ZA200705145B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04078527 2004-12-24

Publications (1)

Publication Number Publication Date
ZA200705145B true ZA200705145B (en) 2009-09-30

Family

ID=34928779

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200705145A ZA200705145B (en) 2004-12-24 2007-06-21 Rescue of influenza virus

Country Status (20)

Country Link
US (2) US7959930B2 (fr)
EP (2) EP2295542B1 (fr)
JP (2) JP5620048B2 (fr)
KR (1) KR101272487B1 (fr)
CN (1) CN101379183B (fr)
AU (1) AU2005318087B2 (fr)
BR (1) BRPI0518568A2 (fr)
CA (1) CA2592439C (fr)
DK (1) DK1831357T3 (fr)
ES (1) ES2395813T3 (fr)
HK (1) HK1125674A1 (fr)
IL (1) IL183888A (fr)
MX (1) MX2007007889A (fr)
NO (1) NO20073737L (fr)
NZ (1) NZ556061A (fr)
PT (1) PT1831357E (fr)
RU (2) RU2435855C2 (fr)
TW (2) TWI495724B (fr)
WO (1) WO2006067211A1 (fr)
ZA (1) ZA200705145B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2435180C (fr) 2001-01-19 2019-04-09 Vironovative B.V. Virus provoquant des maladies respiratoires chez des mammiferes y etant sensibles
CA2477234C (fr) 2002-02-21 2014-12-30 Medimmune Vaccines, Inc. Souches de metapneumovirus et leur utilisation dans des preparations vaccinales et comme vecteurs d'expression de sequences antigeniques
BRPI0518568A2 (pt) * 2004-12-24 2008-11-25 Solvay Pharm Bv mÉtodo para produzir uma partÍcula do vÍrus da influenza replicativo sem o uso de vÍrus auxiliar, partÍcula de vÍrus da influenza replicativo, cÉlula, composiÇço, uso de uma composiÇço, mÉtodo para gerar proteÇço imunolàgica contra infecÇço de um indivÍduo com um vÍrus da influenza, e, Ácido nuclÉico
US7790434B2 (en) 2005-06-21 2010-09-07 Medimmune, Llc Methods and compositions for expressing negative-sense viral RNA in canine cells
WO2007002008A2 (fr) 2005-06-21 2007-01-04 Medimmune Vaccines, Inc. Procedes et compositions permettant d'exprimer un virus a arn sens negatif dans des cellules canines
KR20080069232A (ko) 2005-11-04 2008-07-25 노바티스 백신즈 앤드 다이아그노스틱스 에스.알.엘. 스플리트 인플루엔자 백신에 대한 보조제로서 유리 수성상계면활성제를 갖는 에멀젼
JP2009514850A (ja) 2005-11-04 2009-04-09 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル アジュバントとして減少した量の水中油型エマルションを有するインフルエンザワクチン
EP2368572B1 (fr) 2005-11-04 2020-03-04 Seqirus UK Limited Vaccins avec adjuvants dotés d'antigènes non virioniques préparés à partir de virus de la grippe cultivés dans une culture cellulaire
NZ568211A (en) 2005-11-04 2011-11-25 Novartis Vaccines & Diagnostic Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
NZ592713A (en) 2005-11-04 2012-12-21 Novartis Vaccines & Diagnostic Adjuvanted influenza vaccines including a cytokine-inducing agents other than an agonist of Toll-Like Receptor 9
KR20110110853A (ko) 2006-01-27 2011-10-07 노파르티스 파르마 아게 적혈구응집소 및 기질 단백질을 함유한 인플루엔자 백신
US20100068223A1 (en) 2006-03-24 2010-03-18 Hanno Scheffczik Storage of Influenza Vaccines Without Refrigeration
AU2007245192B2 (en) 2006-03-31 2012-04-12 Wisconsin Alumni Research Foundation High titer recombinant influenza viruses for vaccines
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
GB0614460D0 (en) 2006-07-20 2006-08-30 Novartis Ag Vaccines
CA3016948A1 (fr) 2006-09-11 2008-03-20 Seqirus UK Limited Fabrication de vaccins contre le virus grippal sans utiliser d'oeufs
PL2121011T3 (pl) 2006-12-06 2014-10-31 Novartis Ag Szczepionki zawierające antygeny czterech szczepów wirusa grypy
US9474798B2 (en) 2007-06-18 2016-10-25 Wisconsin Alumni Research Foundation Influenza M2 protein mutant viruses as live influenza attenuated vaccines
EA201070066A1 (ru) 2007-06-27 2010-06-30 Новартис Аг Вакцины против гриппа с низким содержанием добавок
GB0810305D0 (en) 2008-06-05 2008-07-09 Novartis Ag Influenza vaccination
EP2268309B1 (fr) 2008-03-18 2015-01-21 Novartis AG Améliorations dans la préparation des antigènes pour le vaccin contre le virus de la grippe
CA2752039A1 (fr) 2009-02-10 2010-08-19 Novartis Ag Regimes de vaccin antigrippal pour souches liees a une pandemie
WO2010092477A1 (fr) 2009-02-10 2010-08-19 Novartis Ag Vaccins contre l'influenza possédant des quantités accrues d'antigène h3
EA201500910A1 (ru) 2009-02-10 2016-04-29 Новартис Аг Вакцины против гриппа со сниженным количеством сквалена
DE102010018462A1 (de) 2009-04-27 2011-04-07 Novartis Ag Impfstoffe zum Schutz gegen Influenza
EP2459722B1 (fr) 2009-07-31 2017-09-06 Seqirus UK Limited Systemes de genetique inverse
ES2813347T3 (es) 2009-10-26 2021-03-23 Wisconsin Alumni Res Found Virus recombinantes de la influenza de alto título con replicación mejorada en células Vero
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
JP2013529913A (ja) * 2010-06-02 2013-07-25 アヴィール グリーン ヒルズ バイオテクノロジー リサーチ ディベロプメント トレード アクチエンゲゼルシャフト Ｒｎａウィルスの作製のための方法及びヘルパーウィルス
FR2962739B1 (fr) * 2010-07-13 2014-01-31 Univ Claude Bernard Lyon Souches virales modifiees et procede pour ameliorer la production de semences vaccinales de virus influenza
CA2852857A1 (fr) 2011-10-20 2013-04-25 Novartis Ag Vaccins avec adjuvant contre le virus grippal b pour primo-vaccination pediatrique
GB201218195D0 (en) 2012-10-10 2012-11-21 Istituto Zooprofilattico Sperimentale Delle Venezie Composition
US10080794B2 (en) 2013-03-15 2018-09-25 University Of Maryland, College Park Swine influenza viruses and constructs and uses thereof
EP3022296B1 (fr) 2013-07-15 2022-12-28 Wisconsin Alumni Research Foundation Virus influenza recombinés à titre élevé avec augmentation de la réplication dans les oeufs ou les cellules de la lignée vero ou mdck
WO2015196150A2 (fr) 2014-06-20 2015-12-23 Wisconsin Alumni Research Foundation (Warf) Mutations conférant une stabilité génétique à des gènes supplémentaires dans des virus de la grippe
US10633422B2 (en) 2015-06-01 2020-04-28 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
EP3307761A4 (fr) 2015-06-09 2019-01-16 Sanofi Pasteur Inc. Procédés d'optimisation de séquences nucléotidiques codant pour des protéines de la grippe ingéniérisées
JP2018524323A (ja) 2015-06-26 2018-08-30 セキラス ユーケー リミテッド 抗原がマッチしたインフルエンザワクチン
US9890363B2 (en) 2015-07-06 2018-02-13 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication for vaccine development
EP3764098B1 (fr) 2015-07-07 2022-11-16 Seqirus UK Limited Dosage de la puissance de la grippe
EP3417056A1 (fr) 2016-02-19 2018-12-26 Wisconsin Alumni Research Foundation (WARF) Réplication améliorée du virus de la grippe b pour l'élaboration de vaccin
WO2020167432A2 (fr) 2019-01-23 2020-08-20 Yoshihiro Kawaoka Mutations conférant une stabilité génétique à des gènes supplémentaires dans des virus de la grippe
CN113874496A (zh) 2019-02-08 2021-12-31 威斯康星校友研究基金会(Warf) 人源化细胞系
US11390649B2 (en) 2019-05-01 2022-07-19 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication for vaccine development
EP4022046A2 (fr) 2019-08-27 2022-07-06 Wisconsin Alumni Research Foundation (WARF) Virus de la grippe recombinants à ha stabilisé pour réplication dans des oeufs

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
US5854037A (en) 1989-08-28 1998-12-29 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand RNA virus expression systems and vaccines
US6001634A (en) 1989-08-28 1999-12-14 Palese; Peter Recombinant negative strand RNA viruses
US6887699B1 (en) 1990-05-22 2005-05-03 Medimmune Vaccines, Inc. Recombinant negative strand RNA virus expression systems and vaccines
US6544785B1 (en) 1998-09-14 2003-04-08 Mount Sinai School Of Medicine Of New York University Helper-free rescue of recombinant negative strand RNA viruses
US8715940B2 (en) * 1999-04-06 2014-05-06 Wisconsin Alumni Research Foundation Method of making recombinant influenza virus
DK1185615T3 (da) 1999-04-06 2007-11-05 Wisconsin Alumni Res Found Rekombinante influenzavirus til vacciner og genterapi
ATE353370T1 (de) 1999-07-14 2007-02-15 Sinai School Medicine In vitro-rekonstitution von segmentierten, negativstrang-rna-viren
JP2003506039A (ja) * 1999-08-02 2003-02-18 ワイス ｃＤＮＡからの流行性耳下腺炎ウイルスのレスキュー
US6764685B1 (en) * 2000-03-21 2004-07-20 Medimmune Vaccines, Inc. Recombinant parainfluenza virus expression systems and vaccines
SI1317559T1 (sl) 2000-04-28 2009-04-30 St Jude Childrens Res Hospital Sistem transfekcije dna za pripravo infektivne negativne verige virusne rna
KR20030013451A (ko) * 2000-06-23 2003-02-14 아메리칸사이아나미드컴파니 인플루엔자 에이/유돈/72(에이치3엔2) 게놈의뉴클레오타이드 서열
CA2477234C (fr) * 2002-02-21 2014-12-30 Medimmune Vaccines, Inc. Souches de metapneumovirus et leur utilisation dans des preparations vaccinales et comme vecteurs d'expression de sequences antigeniques
DK1499348T3 (en) * 2002-04-26 2015-01-05 Medimmune Llc PROCEDURE FOR PREPARING INFECTIOUS INFLUENZA B-VIRA IN CELL CULTURE
US7037707B2 (en) * 2003-09-04 2006-05-02 St. Jude Children's Research Hospital Method for generating influenza viruses and vaccines
BRPI0518568A2 (pt) * 2004-12-24 2008-11-25 Solvay Pharm Bv mÉtodo para produzir uma partÍcula do vÍrus da influenza replicativo sem o uso de vÍrus auxiliar, partÍcula de vÍrus da influenza replicativo, cÉlula, composiÇço, uso de uma composiÇço, mÉtodo para gerar proteÇço imunolàgica contra infecÇço de um indivÍduo com um vÍrus da influenza, e, Ácido nuclÉico

Also Published As

Publication number Publication date
TWI495724B (zh) 2015-08-11
BRPI0518568A2 (pt) 2008-11-25
KR101272487B1 (ko) 2013-06-07
AU2005318087A1 (en) 2006-06-29
RU2011122117A (ru) 2012-12-10
CN101379183A (zh) 2009-03-04
ES2395813T3 (es) 2013-02-15
TWI402344B (zh) 2013-07-21
PT1831357E (pt) 2012-12-17
AU2005318087B2 (en) 2011-04-21
EP1831357A1 (fr) 2007-09-12
WO2006067211A1 (fr) 2006-06-29
TW200636070A (en) 2006-10-16
RU2435855C2 (ru) 2011-12-10
US7959930B2 (en) 2011-06-14
KR20070110838A (ko) 2007-11-20
NZ556061A (en) 2009-06-26
JP5702321B2 (ja) 2015-04-15
NO20073737L (no) 2007-09-21
HK1125674A1 (en) 2009-08-14
IL183888A (en) 2013-05-30
RU2007128336A (ru) 2009-01-27
US20080050401A1 (en) 2008-02-28
US20120156241A1 (en) 2012-06-21
CA2592439C (fr) 2014-06-03
CN101379183B (zh) 2013-07-03
EP1831357B1 (fr) 2012-10-17
JP5620048B2 (ja) 2014-11-05
IL183888A0 (en) 2007-10-31
JP2008525003A (ja) 2008-07-17
MX2007007889A (es) 2008-01-22
EP2295542B1 (fr) 2013-01-30
CA2592439A1 (fr) 2006-06-29
DK1831357T3 (da) 2012-12-10
TW201235472A (en) 2012-09-01
EP2295542A1 (fr) 2011-03-16
JP2012147789A (ja) 2012-08-09

Similar Documents

Publication Publication Date Title
IL183888A0 (en) Rescue of influenza virus
EP1603590A4 (fr) Vaccin contre le virus de la grippe
EP1766094A4 (fr) Composition de vaccin contre le virus de la grippe et ses methodes d'utilisation
SG2014012868A (en) Functional influenza virus like particles (vlps)
EP1828414A4 (fr) Detection du virus du papillome humain
ZA200802501B (en) Indenoisoquinolinone analogs and methods of use thereof
IL182817A0 (en) Defective influenza virus particles
PT2589602T (pt) Desenvolvimento de componentes de vacina contra o vírus da dengue
EP1796719A4 (fr) Compositions vaccinales antigrippales stables a des temperatures de refrigerateur
EP1874731A4 (fr) Analogues de quinobenzoxazines et procedes d'utilisation de ceux-ci
HK1112846A1 (en) Canine influenza virus and related compositions and methods of use
HK1214534A1 (zh) 流感疫苗
ZA200809056B (en) Influenza virus vaccine
NO20043305D0 (no) Preparation of lodixanol
PT1789593T (pt) Formas solúveis de glicoproteína g de vírus hendra
DE502004010641D1 (de) Atemschutzmaske
EP1872794A4 (fr) Vaccin nasal
EP1728515A4 (fr) Inhibiteur de l'infection par le virus de la grippe
GB2414446B (en) Fall arrest assembly
ZA200703793B (en) Defective influenza virus particles
ITMI20041086A1 (it) Procedimento per la preparazione di idrocarbilalogenuri
GB0411759D0 (en) Safety mask
GB0505491D0 (en) Treatment of influenza
AT501354A3 (de) Atemmaske
GB0427190D0 (en) Chemotherapy of viruses